Compare SRCE & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRCE | QDEL |
|---|---|---|
| Founded | 1863 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | SRCE | QDEL |
|---|---|---|
| Price | $66.58 | $30.14 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $71.25 | $39.33 |
| AVG Volume (30 Days) | 69.0K | ★ 1.2M |
| Earning Date | 01-22-2026 | 11-05-2025 |
| Dividend Yield | ★ 2.50% | N/A |
| EPS Growth | ★ 14.53 | N/A |
| EPS | ★ 6.01 | N/A |
| Revenue | $405,363,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $18.73 | N/A |
| Revenue Next Year | $2.28 | $2.42 |
| P/E Ratio | $10.67 | ★ N/A |
| Revenue Growth | ★ 9.59 | N/A |
| 52 Week Low | $52.14 | $19.50 |
| 52 Week High | $67.77 | $49.45 |
| Indicator | SRCE | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 71.97 | 66.60 |
| Support Level | $62.93 | $26.84 |
| Resistance Level | $65.35 | $28.30 |
| Average True Range (ATR) | 1.45 | 1.31 |
| MACD | 0.35 | 0.53 |
| Stochastic Oscillator | 93.29 | 99.27 |
1st Source Corp, along with its subsidiary, offers banking services. The bank provides Commercial, Agricultural, and Real Estate Loans, which are given to privately owned business clients mainly located within the regional market areas, Consumer Services that consist of the full range of consumer banking products and services, Trust and Wealth Advisory Services, and Insurance services to individuals and business clients. Its Specialty Finance Group offers financing services for construction equipment, new and pre-owned private and cargo aircraft, and various vehicle types for fleet purposes.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.